KBA-1704

N/A

Report date: 2023/12/22 11:25:21

Base Information

Drug NameKBA-1704
Drug Alias NameKBA1704KBA-1704
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Desmoglein-2
TargetsDesmoglein-2
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKling Biotherapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesKling Biotherapeutics BV
Inactive CompaniesN/A
Active IndicationsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A